Related Experiment Video
Updated: May 25, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
XMRV Discovery and Prostate Cancer-Related Research
David E Kang1, Michael C Lee, Jaydip Das Gupta
1Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Abstract:
Xenotropic murine leukemia virus-related virus (XMRV) was first reported in 2006 in a study of human prostate cancer patients with genetic variants of the antiviral enzyme, RNase L. Subsequent investigations in North America, Europe, Asia, and Africa have either observed or failed to detect XMRV in patients (prostate cancer, chronic fatigue syndrome-myalgic encephalomyelitis (CFS-ME), and immunosuppressed with respiratory tract infections) or normal, healthy, control individuals. The principal confounding factors are the near ubiquitous presence of mouse-derived reagents, antibodies and cells, and often XMRV itself, in laboratories. XMRV infects and replicates well in many human cell lines, but especially in certain prostate cancer cell lines. XMRV also traffics to prostate in a nonhuman primate model of infection. Here, we will review the discovery of XMRV and then focus on prostate cancer-related research involving this intriguing virus.
Insights
Xenotropic murine leukemia virus-related virus (XMRV) was linked to human prostate cancer, but its presence is debated due to lab contamination. Further research is needed to clarify XMRV
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- Xenotropic murine leukemia virus-related virus (XMRV) was first identified in 2006.
- Initial studies linked XMRV to human prostate cancer patients with RNase L genetic variants.
Purpose of the Study:
- To review the discovery of XMRV.
- To focus on prostate cancer research involving XMRV.
Main Methods:
- Review of existing scientific literature on XMRV.
- Analysis of studies investigating XMRV detection in various patient groups and healthy controls.
- Examination of XMRV replication in human cell lines and its tropism in primate models.
Main Results:
- Subsequent investigations globally yielded conflicting results regarding XMRV detection in patients and controls.
- Mouse-derived reagents and laboratory contamination are identified as significant confounding factors.
- XMRV demonstrates efficient replication in human cell lines, particularly prostate cancer cells, and targets the prostate in primate models.
Conclusions:
- The presence and role of XMRV in human diseases, including prostate cancer, remain uncertain.
- Laboratory practices and contamination issues are critical considerations in XMRV research.
- XMRV's biological characteristics warrant continued investigation, especially concerning its potential link to prostate cancer.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
07:03Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
Published on: February 3, 2021
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
Cancer Prevention
Some...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...